Top Markets
#1 CyberDEX CyberDEX +391.95%
#2 OVERTAKE OVERTAKE +58.99%
#3 Clearpool Clearpool +25.94%
#4 Playnance Playnance +23.93%
#5 deBridge deBridge +22.97%
#6 B3 (Base) B3 (Base) +20.83%
#7 Nillion Nillion +19.56%
#8 AUKI AUKI +19.09%
#9 Codatta Codatta +17.25%
#10 龙虾 (Lobster) 龙虾 (Lobster) +17.03%
Coin of the day
CyberDEX CyberDEX
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Nuformix plc Nuformix plc

Nuformix plc

NFX
Pozycja w akcjach #41014
Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes... Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes in developing therapies for fibrotic diseases and cancer, primarily through the innovative strategy of drug repurposing. Its current development portfolio includes NXP001, which has advanced beyond Phase 1 trials for application in oncology supportive care. Additionally, the company is progressing NXP004, a novel variant of Olaparib, currently in its intellectual property generation stage for oncological indications, and NXP002, which is undergoing pre-clinical evaluation for the treatment of idiopathic pulmonary fibrosis. Nuformix also holds an option agreement with Oxilio Ltd. concerning NXP001 for its oncology applications. Established in 2008, the company maintains its operational base in London.
Cena akcji
$0.00185055
Kapitalizacja rynkowa
$48.29K
Zmiana (1 dzień)
-3.55%
Zmiana (1 rok)
30.31%
Kraj
GB
Handel Nuformix plc (NFX)

Kategoria

Healthcare
Wskaźnik P/S dla Nuformix plc (NFX)
Wskaźnik P/S na dzień September 2026 TTM: 0.00
Według najnowszych raportów finansowych i ceny akcji Nuformix plc, obecny wskaźnik P/S (TTM) wynosi 0.00. Na koniec 2024 wynosił 0.00.
Historia wskaźnika P/S dla Nuformix plc od 2014 do 2026
Wskaźnik P/S na koniec każdego roku
Rok Wskaźnik P/S Zmień
2026 (TTM) 0.00 0.00%
2025 0.00 0.00%
2024 0.00 0.00%
2023 0.00 -100.00%
2022 116.70 74.68%
2021 66.81 87.30%
2020 35.67 81.62%
2019 19.64 -95.96%
2018 485.61 0.00%
2017 0.00 -100.00%
2016 2.23 0.00%
2014 0.00 0.00%
Wskaźnik P/S dla podobnych firm lub konkurentów
Firma Wskaźnik P/S Różnica wskaźnika P/S Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.44 -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
26.12 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.76 -
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
12.01 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH